University of Miami

The University of Miami is a private research university whose Miller School of Medicine hosted much of the early United States academic work on ibogaine and its principal metabolite noribogaine. Research groups based there carried out pharmacological and preclinical studies, contributed to the characterization of ibogaine metabolism, and were associated with investigational human research conducted in the 1990s under federal review. Publications and patents originating from that work are cited throughout the scientific literature on ibogaine and appear repeatedly among the references on this wiki, particularly on pharmacology, metabolism and cardiac safety topics. Faculty associated with the university have also been involved in later pharmaceutical development efforts aimed at producing regulated ibogaine or noribogaine medicines, which links the institution to the commercial as well as the academic history of the field. The university is not a treatment provider and does not administer ibogaine. Its documented contribution is scientific: laboratory research, published data, graduate training of investigators who continued in the field, and the establishment of a body of evidence that later regulatory submissions and observational studies rely on. Where accounts of the university's role rest on unpublished claims rather than published records, this summary omits them.